Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

semaglutide

semaglutide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Ozempic DEVICE, SUBCUTANEOUS 0.25 mg/actuation, 0.5 mg/actuation, 1 mg/actuation      
Wegovy DEVICE, SUBCUTANEOUS 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL      
Rybelsus TABLET, ORAL 3 mg, 7 mg, 14 mg      
Comments:

Ozempic, Rybelsus, and Wegovy are approved for sample use in HH Endocrinology and Diabetes Clinics

Ozempic is non-formulary, not stocked. Inpatients to use home supply of medication. Liraglutide is a formulary drug if needed, contact prescriber to discuss possible interchange.

Wegovy is non-formulary, not stocked. Inpatients may use home supply.

Review: 23 Oct 2018 (Ozempic), 28 January 2020 (Rybelsus), December 2021 (Wegovy)

Last updated: Jan. 24, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved